Xue, Yan
Li, Jin
Xu, Yu-Nan
Cui, Jia-Sheng
Li, Yue
Lu, Yao-Qiong
Luo, Xiao-Zhi
Liu, De-Zhao
Huang, Feng
Zeng, Zhi-Yu
Huang, Rong-Jie
Funding for this research was provided by:
National Natural Science Foundation of China (81960082, 81860087)
Guangxi Key Laboratory of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention (22-035-18)
Guangxi Clinical Research Center for Cardio-Cerebrovascular Diseases (AD17129014)
Key R&D Program of Guangxi (Guike AB20297008)
Guangxi Medical High-level Backbone Talents “139” Program (G201901006)
Clinical Research Climbing Program of the First Affiliated Hospital of Guangxi Medical University (YYZS2021003)
China National Science and Technology Pillar Program (2011BAI11B01)
Article History
Received: 12 June 2023
Accepted: 22 September 2023
First Online: 2 October 2023
Declarations
:
: This study was conducted in strict accordance with the Declaration of Helsinki, and all participants provided written informed consent. All survey protocols were approved by the Ethics Committee of The First Affiliated Hospital of Guangxi Medical University (Guangxi, China) (approval number: 2012[KY-E-017]).
: Not applicable.
: The authors declare no competing interests.